Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Sep, 2016 | Pages:
80 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The global transcatheter valve market is anticipated to reach a value of USD 8.62 billion by 2024, according to a new report by Grand View Research, Inc. The market is currently under-penetrated as these products are approved only for geriatric patients who cannot undergo normal valve surgeries. Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic development, improvement in reimbursement scenario, and faster adoption of new technologies are expected to significantly improve the usage rates over the forecast period. The transcatheter valve market is evolving rapidly due to the continuous investments in R&D by the key market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve are designed to reduce the surgical complications and improve patient compliance. For instance, the TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on patient safety and treatment outcomes. Furthermore, the market is expected to experience strong tailwinds on account of growing investor interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire potential start-ups. For example, some of the notable investments in the market include the USD 37 million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their investments to develop new products for management of mitral valve regurgitation and tricuspid valve replacements. Further key findings from the study suggest: Aortic stenosis is the most prevalent valve disease, and if untreated it can lead to death. In 2015, transcatheter aortic valve segment accounted for the maximum revenue of over USD 1.6 billion and is expected to retain its dominant share over the forecast period. However, the transcatheter mitral valve segment is expected to emerge as the fastest growing with a CAGR of 23% over the forecast period. Increasing number of elderly patients with mitral regurgitation and growing demand for technologically advanced transcatheter valve devices are expected to drive the usage of transcatheter mitral valves over the forecast period. In 2015, the self-expanded transcatheter accounted for the largest market share of 65%. These catheters are most commonly used and, currently, most of the products that are available in the market are based on this technology. However, balloon expanded transcatheters are expected to have the fastest CAGR of 16.8% over the forecast period. North America held the maximum share of nearly49% in 2015. A combination of different factors such as the presence of large target population, high disposable income, strong reimbursement framework, contribute toward the high revenue generated in this region. Asia Pacific is anticipated to register the fastest CAGR of 17.8% over the forecast period. Increasing disease burden, improvement in clinical trial regulations, growing preference for advanced medical technologies, increase in medical tourism, and special incentives for investments in healthcare sector are expected to strongly favor the growth in this region. Some key market players Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis. ValveXchange, Edwards Lifesciences, and Medtronic are the early movers in this market have captured significant market share in the North America, Europe, and the Asia Pacific region.
Table of Contents
Chapter 1 Executive Summary Chapter 2 Market Snapshot Chapter 3 Market Variables, Trends,& Scope 3.1 Market Segmentation &Scope 3.1.1 Market Driver Analysis 3.1.1.1 Growing prevalence of cardiovascular disorder 3.1.1.2 Growing prevalence heart and vascular system conditions 3.1.1.3 Insurance coverage & reimbursement scenario 3.1.2 Market Restraint Analysis 3.1.2.1 Lack of awareness 3.2 Penetration &Growth Prospect Mapping 3.3 Transcatheter Valve - SWOT Analysis, by Factor (political & legal, economic, and technological) 3.4 Industry Analysis - Porter's Chapter 4 Market Categorization 1: Application Estimates & Trend Analysis 4.1 Transcatheter Valve Market: Application Movement Analysis 4.2 Transcatheter Aortic Valve 4.2.1 Transcatheter Aortic Valve Amplifiers Market Estimates and Forecasts, 2013 - 2024 (USD Million) 4.3 Transcatheter Pulmonary Valve 4.3.1 Transcatheter Pulmonary Valve Market Estimates and Forecasts, 2013 - 2024 (USD Million) 4.4 Transcatheter Mitral Valve 4.4.1 Transcatheter Mitral Valve Market Estimates and Forecasts, 2013 - 2024 (USD Million) Chapter 5 Market Categorization 2: Technology Estimates & Trend Analysis 5.1 Transcatheter Valve Market: TechnologyMovement Analysis 5.2 Ballon Expanded Transcatheter Valve 5.2.1 Ballon Expanded Transcatheter Valve Market Estimates and Forecasts, 2013 - 2024 (USD Million) 5.3 Self-Expanded Transcatheter Valve 5.3.1 Self-Expanded Transcatheter Valve Market Estimates and Forecasts, 2013 - 2024 (USD Million) Chapter 6 Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application 6.1 Transcatheter Valve Market Share by region, 2013 & 2024 6.2 North America 6.2.1 North America Transcatheter Valve Market Estimates and Forecasts, 2013 - 2024(USD Million) 6.2.2 U.S. 6.2.2.1 U.S. transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) 6.2.3 Canada 6.2.3.1 Canada transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) 6.3 Europe 6.3.1. Europe Transcatheter Valve Market Estimates and Forecasts, 2013 - 2024 (USD Million) 6.3.2 Germany 6.3.2.1 Germany transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) 6.3.3 UK 6.3.3.1 UK transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) 6.4 Asia Pacific 6.4.1 Asia Pacific Transcatheter Valve Market Estimates and Forecasts, 2013 - 2024 (USD Million) 6.4.2 Japan 6.4.2.1 Japan transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) 6.4.3 China 6.4.3.1 China transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) 6.5 Latin America 6.5.1 Latin America Transcatheter Valve Market Estimates and Forecasts, 2013 - 2024 (USD Million) 6.5.2 Brazil 6.5.2.1 Brazil transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) 6.5.3 Mexico 6.5.3.1 Mexico transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) 6.6 MEA 6.6.1 MEA Transcatheter Valve Market Estimates and Forecasts, 2013 - 2024 (USD Million) 6.6.2 South Africa 6.6.2.1 South Africa transcatheter valve market estimates and forecasts, 2013 - 2024 (USD Million) Chapter 7 Competitive Landscape 7.1 Strategy Framework 7.2 Market Participation Categorization 7.3 Company Profiles 7.3.1 Boston Scientific Corporation 7.3.1.1 Company Overview 7.3.1.2 Financial Performance 7.3.1.3 Product Benchmarking 7.3.1.4 Strategic Initiatives 7.3.2 Bracco Group 7.3.2.1 Company Overview 7.3.2.2 Financial Performance 7.3.2.3 Product Benchmarking 7.3.2.4 Strategic Initiatives 7.3.3 Braile Biomedica 7.3.3.1 Company Overview 7.3.3.2 Financial Performance 7.3.3.3 Product Benchmarking 7.3.3.4 Strategic Initiatives 7.3.4 Direct Flow Medical 7.3.4.1 Company Overview 7.3.4.2 Financial Performance 7.3.4.3 Product Benchmarking 7.3.4.4 Strategic Initiatives 7.3.5 Edwards Lifesciences Corporation 7.3.5.1 Company Overview 7.3.5.2 Financial Performance 7.3.5.3 Product Benchmarking 7.3.5.4 Strategic Initiatives 7.3.6 Hansen Medical 7.3.6.1 Company Overview 7.3.6.2 Financial Performance 7.3.6.3 Product Benchmarking 7.3.6.4 Strategic Initiatives 7.3.7 JenaValve 7.3.7.1 Company Overview 7.3.7.2 Financial Performance 7.3.7.3 Product Benchmarking 7.3.7.4 Strategic Initiatives 7.3.8 Medtronic 7.3.8.1 Company Overview 7.3.8.2 Financial Performance 7.3.8.3 Product Benchmarking 7.3.8.4 Strategic Initiatives 7.3.9 St. Jude Medical 7.3.9.1 Company Overview 7.3.9.2 Financial Performance 7.3.9.3 Product Benchmarking 7.3.9.4 Strategic Initiatives 7.3.10 Symetis 7.3.10.1 Company Overview 7.3.10.2 Financial Performance 7.3.10.3 Product Benchmarking 7.3.10.4 Strategic Initiatives 7.3.11 ValveXchange 7.3.11.1 Company Overview 7.3.11.2 Financial Performance 7.3.11.3 Product Benchmarking 7.3.11.4 Strategic Initiatives
List of Tables
TABLE 1 Global transcatheter valve market revenue, by application, 2013 - 2024 (USD Million) TABLE 2 Global transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 3 Global transcatheter valve market revenue, by region, 2013 - 2024 (USD Million) TABLE 4 North America transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 5 North America transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 6 U.S. transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 7 U.S. transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 8 Canada transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 9 Canada transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 10 Europe transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 11 Europe transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 12 Germany transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 13 Germany transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 14 UK transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 16 UK transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 17 Asia Pacific transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 18 Asia Pacific transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 19 Japan transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 20 Japan transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 21 China transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 22 China transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 23 Latin America transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 24 Latin America transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 25 Brazil transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 26 Brazil transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 27 Mexico transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 28 Mexico transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 29 MEA transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 30 MEA transcatheter valve market, by technology, 2013 - 2024 (USD Million) TABLE 31 South Africa transcatheter valve market, by application, 2013 - 2024 (USD Million) TABLE 32 South Africa transcatheter valve market, by technology, 2013 - 2024 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
